Arbutus Biopharma Aktie Analyse
16.10.18 | Arbutus Biopharma Buy | B. Riley FBR | |
15.10.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
12.10.18 | Arbutus Biopharma Buy | Chardan Capital Markets | |
06.07.18 | Arbutus Biopharma Neutral | B. Riley FBR, Inc. | |
19.03.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
19.03.18 | Arbutus Biopharma Buy | Chardan Capital Markets | |
05.01.18 | Arbutus Biopharma Buy | B. Riley FBR, Inc. | |
04.04.17 | Arbutus Biopharma Buy | Chardan Capital Markets | |
Werbung
|
|||
01.02.17 | Arbutus Biopharma Outperform | Wedbush Morgan Securities Inc. | |
13.12.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
30.11.16 | Arbutus Biopharma Buy | Chardan Capital Markets | |
14.10.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
08.07.16 | Arbutus Biopharma Sell | Chardan Capital Markets | |
16.06.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
16.05.16 | Arbutus Biopharma Sell | Chardan Capital Markets | |
06.11.15 | Arbutus Biopharma Outperform | RBC Capital Markets |